NASDAQ:ENOB Investor Notice: Deadline on September 26, 2022 in Lawsuit Against Enochian Biosciences, Inc.
A Deadline is coming up on September 26, 2022 in the lawsuit for certain investors in Enochian Biosciences, Inc. (NASDAQ:ENOB).
San Diego, CA -- (SBWire) -- 09/26/2022 --A deadline is coming up on September 26, 2022 in the lawsuit filed for certain investors of Enochian Biosciences, Inc. (NASDAQ: ENOB).
Investors who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and there are strict and short deadlines running. Deadline: September 26, 2022. NASDAQ: ENOB stockholders should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Enochian Biosciences, Inc. (NASDAQ: ENOB) common shares between September 24, 2020 and May 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 24, 2020 and May 31, 2022, the Defendants made false and/or misleading statements and/or failed to disclose thatGumrukcu was not a licensed doctor and had no verifiable degrees beyond high school, that accordingly, the scientific and technological underpinnings of Enochian's product pipeline, purportedly invented by Gumrukcu, were dubious at best, that accordingly, the Defendants had significantly overstated the commercial prospects for the Company's product pipeline, that Enochian's senior leadership knew Gumrukcu had a criminal history that included fraud, that accordingly, Enochian's reliance on Gumrukcu, and its consulting and licensing agreements with G-Tech and SRI, subjected the Company to a heightened risk of reputational and financial harm, as well as threatened the integrity of the Company's scientific findings, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Media Relations Contact
Shareholders Foundation, Inc.
View this press release online at: http://rwire.com/1364137